A Stratteraohn Capsule – 150 mg is a brand-name prescription medication that contains the active ingredient atomoxetine. It is primarily used to treat attention-deficit hyperactivity disorder (ADHD) and other ADHD symptoms.
A Stratteraohn Capsule – 150 mg is a prescription medication that contains the active ingredient atomoxetine. It is usually taken orally, once or twice a day, with or without food, as directed by your doctor. The dosage and duration of treatment can vary depending on the individual and the condition being treated. Common side effects may include nausea, vomiting, breast tenderness, decreased appetite, headache, and dizziness. In some rare cases, laboratory studies have demonstrated elevated prolactin levels, a hormone that causes the breasts to turn yellow, during sex. Stratteraohn capsules are typically taken with a meal to enhance the effects of the medication.
A Stratteraohn Capsule – 150 mg may also be prescribed by a doctor or may be used as a suppository for injection into the vagina. Your doctor will determine the appropriate dose and duration of treatment if you are experiencing symptoms such as agitation, difficulty with organization of daily life, and irritability or agitation.
A Stratteraohn Capsule – 150 mg can cause some side effects, although they are rare. These side effects can be temporary and include nausea, vomiting, diarrhea, increased appetite, weight gain, dry mouth, etc. If you experience any of these side effects, you should stop taking the Stratteraohn Capsule – 150 mg and notify your doctor immediately. These side effects can be more severe and require medical attention or contact your doctor.
A Stratteraohn Capsule – 150 mg may also cause some milder side effects, such as:
A Stratteraohn Capsule – 150 mg may also cause more serious side effects, such as:
Atomoxetine is the brand name of the medication Strattera.
Atomoxetine, also known by its generic name atomoxetine, is one of several medications by the brand Strattera has come into being that is being sold as a treatment for ADHD in adults. It is therefore highly recommended that you read the patient information leaflet and speak with a healthcare professional before starting the medication. As the patient information leaflet (ive read it) talks about the medication being sold as a treatment for ADHD in adults, the instructions on the packaging or the product label then tell you to speak with a pharmacist or your doctor if you need a prescription for it.
As with all medications, there are some things you should remember when you start taking Strattera. Here are some things you should keep in mind:
Do not take more than the prescribed dose of Strattera– if you do stop taking Strattera, your doctor will likely recommend that you take it again.
If you are not sure whether you are taking Strattera, speak to your doctor or a healthcare professional.
Tell your doctor if you are pregnant or breastfeeding– if you are pregnant or breastfeeding, you should discuss the risks and benefits of taking Strattera during pregnancy or while breastfeeding.
Tell your doctor if you have any of the following conditions:
You should also be aware that you may not be suitable for Strattera and that the risks to you may vary from person to person.
Tell your doctor if you have or have had any medical conditions
If you havea history of suicidal thoughts or behavior, or experience any other changes in your mood or thinking, you should contact your doctor immediately.
Tell any other healthcare professional before taking Strattera–If you have ever had an allergic reaction to atomoxetine or any other medication, including non-controlled substance (Ritalin) substances), or prescription or non-prescription medications
Your doctor or pharmacist will be able to tell you about the symptoms of any possible allergic reaction you may experience and whether or not you should be taken this medication.
It is not recommended to take Strattera if you havea history of heart failure, liver disease, kidney disease, or take certain other medicinesif you have or have ever had certain heart rhythm problems, or if you have ever had a heart attack
– if you are a woman, if you are over 18, or if you are in the first 6 months of pregnancy or breast-feeding
– if you have diabetes, if you have high blood pressure, if you have heart disease, if you have had a stroke, if you have a history of seizures or blood clots, if you are a smoker, if you have or have ever had liver problems, if you have diabetes, if you have a history of heart problems or liver problems, if you are a smoker, if you are a breast-wifter, if you have ever had a heart attack or stroke, if you are breast-feeding or planning to breast-feed, if you are currently pregnant, if you are under 18 or have ever had any problems with your baby’s heart rate, if you are under 24 months old or in the last 6 months of pregnancy, if you are a woman, if you are over 18 or in the first 6 months of pregnancy or breast-feeding, if you have or have ever had any serious mental or emotional problems, if you are a woman, if you are under 25, or if you are in the last 6 months of pregnancy, if you are pregnant, if you are breastfeeding or planning to breast-feed, if you are breastfeeding your baby, or if you plan to breast-feed your baby.
Atomoxetine (Strattera) Medication Information LeafletPlease read the patient information leaflet before taking this medicine.
by|Updated:11:22 BST, 27 May 2011
Strattera, a non-stimulant drug that helps treat bipolar disorder, can help. But it's a little difficult to say whether this is really effective and if it's the right medication for you. The doctor here at the Royal Marsden Hospital has decided to try a different drug, called Strattera, to treat the condition.
It has been prescribed to patients for decades, but doctors can't say if it works for the person taking it, because the side effects that are seen in some people include headache, insomnia and nausea. The drug is not for people taking stimulant medications, which can cause mood swings. But doctors say it could have some serious effects on someone's mood and how they respond to medication. A recent review of the literature suggests there may be rare side effects from Strattera, although the drugs have been known to have side effects of some sort.
Dr Martin J. K. Hoey, director of the Royal Marsden Hospital's Clinical Pharmacology Unit, said: "These are some of the most common side effects that are seen in some patients taking Strattera. We don't know if the side effects seen in patients taking Strattera are actually the side effects of Strattera itself, but we do know that they are seen in patients taking the medicine and in patients with a condition called bipolar disorder."
The side effects seen in some patients taking Strattera are: headache, insomnia, nausea, vomiting, insomnia with an appetite and feeling sick, dry mouth, sweating, dizziness, diarrhoea, diarrhoea, vomiting, diarrhoea, constipation and stomach pain, dry mouth and constipation, confusion, memory loss, dizziness, sleepiness, tinnitus and dizziness. Patients taking Strattera have also experienced a feeling of drowsiness and a feeling of nausea, which may be due to a reaction to the drug itself.
If you have a problem with Strattera, it's best to ask a doctor or pharmacist for advice.
If you are feeling anxious, depressed, confused or feel tired, irritable and anxious you may need to see a doctor who can help you. If your doctor is not available, you may need to take other measures, including treatment for depression. If you have mood problems, talk to your doctor, your GP or pharmacist, as they can help you.
You may also be asked to stop taking Strattera. It's also possible to stop taking it if the doctor has suggested you are an adult and that you are under a doctor's care, such as a family member or a specialist, because they could see that Strattera could be harmful to an unborn child. If you are considering this treatment, you should ask the doctor about the potential risks of using Strattera.
At the Royal Marsden Hospital, the hospital is one of the world's largest, with more than 1,000 hospitals and clinics in more than 100 countries. For more information, visit.
Dr Martin K. Hoey, director of the Royal Marsden Hospital's Clinical Pharmacology Unit, said: "Strattera is a non-stimulant drug that has been used for decades to treat many different conditions. It is a very effective treatment option for patients suffering from bipolar disorder. Our research shows that Strattera can improve symptoms and reduce the risk of serious side effects."
The drug is a non-stimulant that has a half-life of about two hours and was approved in 2000 for use as an inpatient treatment for children and adolescents. It was originally developed by the drug company Eli Lilly, but was later approved by the US Food and Drug Administration (FDA) to treat bipolar disorder.
A recent study of people taking Strattera found that patients taking Strattera were twice as likely to have bipolar disorder as those taking an antidepressant or an antidepressant alone, while taking a placebo was not associated with an increased risk of bipolar disorder. The results of the study show that Strattera has not been studied in people who are taking the drug for the treatment of bipolar disorder.
When taken in the normal doses, the drug works in the brain by affecting chemicals in the brain, such as dopamine and serotonin, which play a crucial role in mood regulation.
Atomoxetine (Strattera) is a medication that is used for treating attention deficit hyperactivity disorder (ADHD). It works by increasing levels of certain chemicals in the body, which improves attention and behavior.
Atomoxetine was initially developed by Eli Lilly as a drug to treat ADHD. It was later approved by the U. S. Food and Drug Administration (FDA) in 2002.
Atomoxetine was developed to treat ADHD by Eli Lilly as a medication. It was approved by the FDA in 2002. Strattera, or atomoxetine, was initially developed to treat attention deficit hyperactivity disorder (ADHD). It was approved by the FDA in the late 1990s.
Atomoxetine was originally developed to treat patients with attention deficit hyperactivity disorder (ADHD) by Eli Lilly. However, it was found that patients with this condition could not tolerate the drug or could not stop taking it without being prescribed Strattera. Eventually Strattera was discontinued, and the medication was approved by the FDA in 2002.
When you’re a child, you have an ability to focus on tasks and concentrate on tasks. In most cases, the hyperactivity problem stems from poor timing in certain areas of your life.
When your child is inattentive, they may notice that your child is doing things that are not there. This is known asattention-deficit/hyperactivity disorder (ADHD). Strattera prevents the body from telling your child what to do in these situations.
Strattera’s effects can be felt when it is started or when it is finished. However, the drug is usually only effective for 30 to 60 minutes after your child has finished taking it.
Atomoxetine has a long list of side effects that can occur with certain medications. The most common side effects include:
Other side effects include:
If you experience any of these side effects or notice any other side effects, talk to your doctor.
If you have any questions about how atomoxetine can reduce ADHD symptoms, contact your doctor.
Atomoxetine (Strattera) is a medication that is taken as a tablet, and is available in multiple doses. The recommended starting dose of atomoxetine is usually 10 mg, which can be adjusted by your doctor based on your response to the medication. If your doctor determines that the dose is right for you, the dose may be increased to 25 mg.
If your doctor has prescribed atomoxetine, your dose of atomoxetine will be based on your weight in kilograms (kg).
Atomoxetine is not approved for use by children younger than 18 years old. However, Eli Lilly and Co. (Lilly) has approved it for use in children.
The medication comes as a tablet to be taken by mouth.
Stade de France Pharmacy